Company intelligence / Profile preview
Sanwa Kagaku Kenkyusho Co., Ltd.
- Ownership
- Private
- Employees
- ~826
- Development stage
- Other
Overview
Sanwa Kagaku Kenkyusho Co., Ltd. ("Sanwa") is an established Japanese pharmaceutical company focused on the R&D, manufacturing, marketing of pharmaceuticals and diagnostic products—especially for diabetes care—and contract manufacturing. It has a broad commercial portfolio including small molecules for diabetes/renal/endocrine/metabolic disorders as well as diagnostics. The company leverages proprietary formulation technologies like OSDrC® and maintains active partnerships to expand its pipeline into rare endocrine diseases.[1][2][3][6]
- Therapeutic areas
- RheumatologyEndocrinologyInfectious DiseasesNephrology
- Modalities
- Small molecule drugs[5]Diagnostic agents[5]Enzymes[5]Biosimilars[5]
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Sanwa Kagaku Kenkyusho Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanwa Kagaku Kenkyusho Co., Ltd..